These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34369435)

  • 21. Clinical outcomes of patients with adenocarcinoma in situ of the cervix treated by conization.
    Taylor JS; Panico V; Caputo T; Gerber D; Gupta D; Pirog E; Holcomb K
    Eur J Gynaecol Oncol; 2014; 35(6):641-5. PubMed ID: 25556268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of loop electrosurgical excisional procedure in the management of adenocarcinoma in situ of the uterine cervix.
    Kim JH; Park JY; Kim DY; Kim YM; Kim YT; Nam JH
    Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):100-3. PubMed ID: 19428171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The safety of conization in the management of adenocarcinoma in situ of the uterine cervix.
    Kim ML; Hahn HS; Lim KT; Lee KH; Kim HS; Hong SR; Kim TJ
    J Gynecol Oncol; 2011 Mar; 22(1):25-31. PubMed ID: 21607092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring uterine involvement in hysterectomy samples following conization for adenocarcinoma in situ of the uterine cervix: Insights from a multicenter study by the FRANCOGYN group.
    Marjolaine LG; Louise B; Meriem K; Enrica B; Pierre-Adrien B; Yohan K; Emilie R; Lise L; Xavier C; Geoffroy C; Charles-André P; Huyen-Thu NX; Anne-Sophie B; Henri A
    J Gynecol Obstet Hum Reprod; 2024 Jul; 53(9):102826. PubMed ID: 39074662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Modalities and limits of conservative treatment of adenocarcinoma in situ of the uterine cervix: analysis of nine cases and review of the literature].
    Omnes S; Morice P; Camatte S; Rouzier R; Pautier P; Pomel C; Lhommé C; Haie-Meder C; Duvillard P; Castaigne D
    Gynecol Obstet Fertil; 2003 Nov; 31(11):912-9. PubMed ID: 14623554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of cervical excisional dimensions on endocervical margins status in adenocarcinoma in situ of the uterine cervix: A multicenter study from the FRANCOGYN group.
    Bartin R; Delangle R; Mergui JL; Azaïs H; Bolze PA; Philip CA; Kerbage Y; Raimond E; Lecointre L; Carcopino X; Castela M; Uzan C; Canlorbe G
    J Gynecol Obstet Hum Reprod; 2023 Sep; 52(7):102622. PubMed ID: 37321399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenocarcinoma in situ of the uterine cervix: Clinical practice guidelines from the Italian society of colposcopy and cervical pathology (SICPCV).
    Ciavattini A; Giannella L; Delli Carpini G; Tsiroglou D; Sopracordevole F; Chiossi G; Di Giuseppe J;
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():273-277. PubMed ID: 31352128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postconization surveillance of cervical adenocarcinoma in situ. A prospective trial.
    Schorge JO; Lea JS; Ashfaq R
    J Reprod Med; 2003 Oct; 48(10):751-5. PubMed ID: 14619639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endocervical adenocarcinoma in situ-from Papanicolaou test to hysterectomy: a series of 74 cases.
    Lashmanova N; Braun A; Cheng L; Gattuso P; Yan L
    J Am Soc Cytopathol; 2022; 11(1):13-20. PubMed ID: 34509373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncologic and obstetric outcomes after conization for adenocarcinoma in situ or stage IA1 cervical cancer.
    Wang X; Bi Y; Wu H; Wu M; Li L
    Sci Rep; 2020 Nov; 10(1):19920. PubMed ID: 33199765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Further study of the management of cervical adenocarcinoma in situ.
    Kennedy AW; Biscotti CV
    Gynecol Oncol; 2002 Sep; 86(3):361-4. PubMed ID: 12217762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenocarcinoma in situ of the uterine cervix: management and outcome.
    Widrich T; Kennedy AW; Myers TM; Hart WR; Wirth S
    Gynecol Oncol; 1996 Jun; 61(3):304-8. PubMed ID: 8641606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors affecting residual lesion in women with cervical adenocarcinoma in situ after cone excisional biopsy.
    Srisomboon J; Kietpeerakool C; Suprasert P; Siriaunkgul S; Khunamornpong S; Prompittayarat W
    Asian Pac J Cancer Prev; 2007; 8(2):225-8. PubMed ID: 17696736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can adenocarcinoma in situ of the uterine cervix be treated safely by conisation in combination with endocervical curettage?
    Booth BB; Petersen LK
    Eur J Gynaecol Oncol; 2014; 35(6):683-7. PubMed ID: 25556275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of cervical adenocarcinoma in situ during pregnancy.
    Lacour RA; Garner EI; Molpus KL; Ashfaq R; Schorge JO
    Am J Obstet Gynecol; 2005 May; 192(5):1449-51. PubMed ID: 15902134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is conservative treatment for adenocarcinoma in situ of the cervix safe?
    Soutter WP; Haidopoulos D; Gornall RJ; McIndoe GA; Fox J; Mason WP; Flanagan A; Nicholas N; Barker F; Abrahams J; Lampert I; Sarhanis P
    BJOG; 2001 Nov; 108(11):1184-9. PubMed ID: 11762660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conservative treatment of stage IA1 adenocarcinoma of the cervix during pregnancy.
    Yahata T; Numata M; Kashima K; Sekine M; Fujita K; Yamamoto T; Tanaka K
    Gynecol Oncol; 2008 Apr; 109(1):49-52. PubMed ID: 18289649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.
    Ostör AG; Duncan A; Quinn M; Rome R
    Gynecol Oncol; 2000 Nov; 79(2):207-10. PubMed ID: 11063645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenocarcinoma in situ of the uterine cervix.
    Muntz HG; Bell DA; Lage JM; Goff BA; Feldman S; Rice LW
    Obstet Gynecol; 1992 Dec; 80(6):935-9. PubMed ID: 1448263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenocarcinoma in situ of the cervix: management and outcome.
    Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
    Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.